Bleomycin combined with Interleukin-2 in the treatment of patients with malignant pleural effusion from NSCLC
- VernacularTitle:博莱霉素联合白细胞介素-2治疗非小细胞肺癌胸腔积液的临床观察
- Author:
Mei HE
- Publication Type:Journal Article
- Keywords:
Bleomycin;
Interleukin-2;
Malignant pleural effusions;
NSCLC
- From:
Cancer Research and Clinic
2006;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and adverse effects of bleomycin combined with Interleukin-2 for malignant pleural effusions in patients with NSCLC. Methods Malignant pleural effusions were excreted cleanly from indwelling chest tube, bleomycin and Interleukin-2 were injected thorax. Results Total survival rate is 88.5 %, only part patients have fever, chest pain, tetter, nausea. Conclusion Bleomycin combined with Interleukin-2 treat patients with malignant pleural effusion from NSCLC, the efficacy are better, the adverse effects are tolerabe.
